These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 38041911)

  • 21. 3D bioprinted liver tissue and disease models: Current advances and future perspectives.
    Sun L; Wang Y; Zhang S; Yang H; Mao Y
    Biomater Adv; 2023 Sep; 152():213499. PubMed ID: 37295133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Grafting of 3D Bioprinting to In Vitro Drug Screening: A Review.
    Nie J; Gao Q; Fu J; He Y
    Adv Healthc Mater; 2020 Apr; 9(7):e1901773. PubMed ID: 32125787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advancements in Research on Constructing Physiological and Pathological Liver Models and Their Applications Utilizing Bioprinting Technology.
    Ming Z; Tang X; Liu J; Ruan B
    Molecules; 2023 Apr; 28(9):. PubMed ID: 37175094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue-engineered heart chambers as a platform technology for drug discovery and disease modeling.
    Mousavi A; Stefanek E; Jafari A; Ajji Z; Naghieh S; Akbari M; Savoji H
    Biomater Adv; 2022 Jul; 138():212916. PubMed ID: 35913255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Applications of Three Dimensional Printing in Cardiovascular Medicine.
    Gardin C; Ferroni L; Latremouille C; Chachques JC; Mitrečić D; Zavan B
    Cells; 2020 Mar; 9(3):. PubMed ID: 32192232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microfluidic bioprinting for organ-on-a-chip models.
    Yu F; Choudhury D
    Drug Discov Today; 2019 Jun; 24(6):1248-1257. PubMed ID: 30940562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3D bioprinting of complex tissues in vitro: state-of-the-art and future perspectives.
    Xiang Y; Miller K; Guan J; Kiratitanaporn W; Tang M; Chen S
    Arch Toxicol; 2022 Mar; 96(3):691-710. PubMed ID: 35006284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Printing Technologies for Medical Applications.
    Shafiee A; Atala A
    Trends Mol Med; 2016 Mar; 22(3):254-265. PubMed ID: 26856235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in 3D Bioprinting for Cancer Biology and Precision Medicine: From Matrix Design to Application.
    Jung M; Ghamrawi S; Du EY; Gooding JJ; Kavallaris M
    Adv Healthc Mater; 2022 Dec; 11(24):e2200690. PubMed ID: 35866252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioprinting on Organ-on-Chip: Development and Applications.
    Chliara MA; Elezoglou S; Zergioti I
    Biosensors (Basel); 2022 Dec; 12(12):. PubMed ID: 36551101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biofabrication: new approaches for tissue regeneration].
    Horch RE; Weigand A; Wajant H; Groll J; Boccaccini AR; Arkudas A
    Handchir Mikrochir Plast Chir; 2018 Apr; 50(2):93-100. PubMed ID: 29378379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3D bioprinting for organ and organoid models and disease modeling.
    Juraski AC; Sharma S; Sparanese S; da Silva VA; Wong J; Laksman Z; Flannigan R; Rohani L; Willerth SM
    Expert Opin Drug Discov; 2023; 18(9):1043-1059. PubMed ID: 37431937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3D Bioprinting of Human Tissues: Biofabrication, Bioinks, and Bioreactors.
    Zhang J; Wehrle E; Rubert M; Müller R
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Operationalizing the Use of Biofabricated Tissue Models as Preclinical Screening Platforms for Drug Discovery and Development.
    Jung O; Song MJ; Ferrer M
    SLAS Discov; 2021 Oct; 26(9):1164-1176. PubMed ID: 34269079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress in 3D bioprinting technology for tissue/organ regenerative engineering.
    Matai I; Kaur G; Seyedsalehi A; McClinton A; Laurencin CT
    Biomaterials; 2020 Jan; 226():119536. PubMed ID: 31648135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3D cell aggregate printing technology and its applications.
    Jeon S; Lee SH; Ahmed SB; Han J; Heo SJ; Kang HW
    Essays Biochem; 2021 Aug; 65(3):467-480. PubMed ID: 34223609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utilization of 3D bioprinting technology in creating human tissue and organoid models for preclinical drug research - State-of-the-art.
    Frankowski J; Kurzątkowska M; Sobczak M; Piotrowska U
    Int J Pharm; 2023 Sep; 644():123313. PubMed ID: 37579828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical Testing Techniques: Paving the Way for New Oncology Screening Approaches.
    van Rijt A; Stefanek E; Valente K
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3D-bioprinted human tissue and the path toward clinical translation.
    Bliley JM; Shiwarski DJ; Feinberg AW
    Sci Transl Med; 2022 Oct; 14(666):eabo7047. PubMed ID: 36223452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Applications of 3D Bioprinting Technology to Brain Cells and Brain Tumor Models: Special Emphasis to Glioblastoma.
    Ozbek II; Saybasili H; Ulgen KO
    ACS Biomater Sci Eng; 2024 May; 10(5):2616-2635. PubMed ID: 38664996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.